The Role of T Regulatory Cells in Immune Senescence

  • Paul MossEmail author
Living reference work entry


T regulatory cells (Treg), defined by the transcription factor FoxP3, play an essential role in immune regulation and are required throughout life. Treg are generated either directly from the thymus or via peripheral T cells which acquire regulatory phenotype when activated in the presence of factors such as TGFβ. The relative contribution of these two populations over the life course is unclear. The number of T regulatory cells increases with age in both mice and humans, and CD4+FoxP3+ cells represent around 4.4% and 5.8% of the CD4+ repertoire in younger (<30 years) and older people (>70 years), respectively. This may relate to increased peripheral conversion from effector cells, methylation at regulatory elements of FoxP3, or reduced expression of apoptotic proteins such as Bim. Importantly, the function of T regulatory cells does not appear to deteriorate with age. There is increasing interest in the potential role of Treg cells in the development of immune senescence. Antibody-mediated CD25 cell depletion can improve immune responses and clinical protection to influenza challenge in aged mice, but translation of these findings to humans has not yet been undertaken. Depletion of Treg cells is a therapeutic aim in the treatment of cancer but complicated by the development of autoimmunity. In addition, cohort studies suggest that increased numbers of regulatory cells may be associated with improved overall survival in older people. T regulatory cells play an essential and complex role in the immune homeostasis of older people, but optimal approaches to therapeutic manipulation are currently uncertain.


T regulatory FoxP3 Aging Immune senescence Autoimmunity 


  1. Abbas AK, Trotta E, Simeonov DR, Marson A, Bluestone JA (2018) Revisiting IL-2: biology and therapeutic prospects. Sci Immunol 3(25):eaat1482CrossRefGoogle Scholar
  2. Allan SE et al (2007) Activation-induced FOXP3 in human T-effector cells does not suppress proliferation or cytokine production. Int Immunol 19(4):345–354CrossRefGoogle Scholar
  3. Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O’Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B, TRACERx Melanoma, TRACERx Renal, TRACERx Lung consortia, Pule M, Marafioti T, Gore M, Larkin J, Turajlic S, Swanton C, Peggs KS, Quezada SA (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell 33(4):649–663CrossRefGoogle Scholar
  4. Arruvito L, Payaslian F, Baz P, Podhorzer A, Billordo A, Pandolfi J et al (2014) Identification and clinical relevance of naturally occurring human CD8+HLA-DR+ regulatory T cells. J Immunol 193(9):4469–4476CrossRefGoogle Scholar
  5. Aspinall R (2006) T-cell development, ageing and Interleukin-7. Mech Ageing Dev 127(6):572–578CrossRefGoogle Scholar
  6. Atarashi K, Umesaki Y, Honda K (2011) Microbiotal influence on T cell subset development. Semin Immunol 23:146–153CrossRefGoogle Scholar
  7. Bektas A, Schurman SH, Sen R, Ferrucci L (2017) Human T cell immunosenescence and inflammation in aging. J Leukoc Biol 102(4):977–988CrossRefGoogle Scholar
  8. Blais ME et al (2008) Why T-cells of thymic versus extrathymic origin are functionally different. J Immunol 180(4):2299–2312CrossRefGoogle Scholar
  9. Borsellino G et al (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg-cells: hydrolysis of extracellular ATP and immune suppression. Blood 110(4):1225–1232CrossRefGoogle Scholar
  10. Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJ, Furman D, Shen-Orr S, Dekker CL, Swan GE, Butte AJ, Maecker HT, Davis MM (2015) Variation in the human immune system is largely driven by non-heritable influences. Cell 160(1–2):37–47CrossRefGoogle Scholar
  11. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27(1):68–73CrossRefGoogle Scholar
  12. Bryl E, Witkowski JM (2004) Decreased proliferative capability of CD4(+) cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T-cells. Exp Gerontol 39(4):587–595CrossRefGoogle Scholar
  13. Carpentier M, Chappert P, Kuhn C et al (2013) Extrathymic induction of Foxp3+ regulatory T cells declines with age in a T-cell intrinsic manner. Eur J Immunol 43:2598–2604CrossRefGoogle Scholar
  14. Chougnet CA, Tripathi P, Lages CS, Raynor J, Sholl A, Fink P, Plas DR, Hildeman DA (2011) A major role for Bim in regulatory T cell homeostasis. J Immunol 186(1):156–163CrossRefGoogle Scholar
  15. Czesnikiewicz-Guzik M et al (2008) T-cell subset-specific susceptibility to aging. Clin Immunol 127(1):107–118CrossRefGoogle Scholar
  16. Darrigues J, van Meerwijk JPM, Romagnoli P (2018) Age-dependent changes in regulatory T lymphocyte development and function: a mini-review. Gerontology 64(1):28–35CrossRefGoogle Scholar
  17. Dejaco C, Duftner C, Schirmer M (2006) Are regulatory T-cells linked with aging? Exp Gerontol 41(4):339–345CrossRefGoogle Scholar
  18. Derhovanessian E, Chen S, Maier AB, Hähnel K, de Craen AJ, Roelofs H, Westendorp R, Pawelec G (2015) CCR4+ regulatory T cells accumulate in the very elderly and correlate with superior 8-year survival. J Gerontol A Biol Sci Med Sci 70(8):917–923CrossRefGoogle Scholar
  19. Dorf ME, Benacerraf B (1984) Suppressor cells and immuno-regulation. Annu Rev Immunol 2:127–157CrossRefGoogle Scholar
  20. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 4(4):330–336CrossRefGoogle Scholar
  21. Garg SK, Delaney C, Toubai T, Ghosh A, Reddy P, Banerjee R, Yung R (2014) Aging is associated with increased regulatory T-cell function. Aging Cell 13(3):441–448CrossRefGoogle Scholar
  22. Goldeck D, Theeten H, Hassouneh F, Oettinger L, Wistuba-Hamprecht K, Cools N, Tsitsilonis OE, Pawelec G (2017) Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine. Vaccine 35(34):4330–4338CrossRefGoogle Scholar
  23. Goronzy JJ, Weyand CM (2012) Immune aging and autoimmunity. Cell Mol Life Sci 69(10):1615–1623CrossRefGoogle Scholar
  24. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, Nayak L, Moss PA (2005) The number of human peripheral blood CD4+ CD25high regulatory T- cells increases with age. Clin Exp Immunol 140(3):540–546CrossRefGoogle Scholar
  25. Han GM, Zhao B, Jeyaseelan S, Feng JM (2009) Age-associated parallel increase of Foxp3(+)CD4(+) regulatory and CD44(+)CD4(+) memory T cells in SJL/J mice. Cell Immunol 258(2):188–196CrossRefGoogle Scholar
  26. Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, Ziegelbauer J, Yassai M, Li SH, Relland LM, Wise PM, Chen A, Zheng YQ, Simpson PM, Gorski J, Salzman NH, Hessner MJ, Chatila TA, Williams CB (2011) A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35(1):109–122CrossRefGoogle Scholar
  27. Harpaz I, Bhattacharya U, Elyahu Y, Strominger I, Monsonego A (2017) Old mice accumulate activated effector CD4 T cells refractory to regulatory T cell-induced immunosuppression. Front Immunol 8:283CrossRefGoogle Scholar
  28. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T-cell development by the transcription factor Foxp3. Science 299(5609):1057–1061CrossRefGoogle Scholar
  29. Hsieh CS et al (2006) An intersection between the self-reactive regulatory and nonregulatory T-cell receptor repertoires. Nat Immunol 7(4):401–410CrossRefGoogle Scholar
  30. Hwang KA, Kim HR, Kang I (2009) Aging and human CD4(+) regulatory T cells. Mech Ageing Dev 130(8):509–517CrossRefGoogle Scholar
  31. Jagger A, Shimojima Y, Goronzy JJ, Weyand CM (2014) Regulatory T cells and the immune aging process: a mini-review. Gerontology 60(2):130–137CrossRefGoogle Scholar
  32. Johnson ND, Wiener HW, Smith AK, Nishitani S, Absher DM, Arnett DK, Aslibekyan S, Conneely KN (2017) Non-linear patterns in age-related DNA methylation may reflect CD4+ T cell differentiation. Epigenetics 12(6):492–503CrossRefGoogle Scholar
  33. Kared H et al (2005) Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54(1):78–84CrossRefGoogle Scholar
  34. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T-cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191–197CrossRefGoogle Scholar
  35. Kiniwa Y et al (2007) CD8+ Foxp3+ regulatory T-cells mediate immuno-suppression in prostate cancer. Clin Cancer Res 13(23):6947–6958CrossRefGoogle Scholar
  36. Kozlowska E et al (2007) Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T-cells in mice. Immunology 122(3):445–453CrossRefGoogle Scholar
  37. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, Hildeman DA, Belkaid Y, Chougnet C (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181(3):1835–1848CrossRefGoogle Scholar
  38. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T (2011) Impact of age on T cell signaling: a general defect or specific alterations? T Ageing Res Rev 10(3):370–378CrossRefGoogle Scholar
  39. Lathrop SK, Santacruz NA, Pham D, Luo J, Hsieh CS (2008) Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med 205(13):3105–3117CrossRefGoogle Scholar
  40. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CS (2012) A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 37(3):475–486CrossRefGoogle Scholar
  41. Liston A, Gray DH (2014) Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 14:154–165CrossRefGoogle Scholar
  42. Liu W et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T-reg cells. J Exp Med 203(7):1701–1711CrossRefGoogle Scholar
  43. Lu L, Barbi J, Pan F (2017) The regulation of immune tolerance by FOXP3. Nat Rev Immunol 17(11):703–717CrossRefGoogle Scholar
  44. Lukas Yani S, Keller M, Melzer FL, Weinberger B, Pangrazzi L, Sopper S, Trieb K, Lobina M, Orrù V, Fiorillo E, Cucca F, Grubeck-Loebenstein B (2018) CD8+HLADR+ regulatory T cells change with aging: they increase in number, but lose checkpoint inhibitory molecules and suppressive function. Front Immunol 9:1201CrossRefGoogle Scholar
  45. Meloni F et al (2006) Foxp3 expressing CD4+ CD25+ and CD8+CD28- T-regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 67(1–2):1–12CrossRefGoogle Scholar
  46. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911CrossRefGoogle Scholar
  47. Nakahara M, Nagayama Y, Ichikawa T, Yu L, Eisenbarth GS, Abiru N (2011) The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages. Autoimmunity 44(6):504–510CrossRefGoogle Scholar
  48. Nikolich-Žugich J (2014) Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J Immunol 193:2622–2629CrossRefGoogle Scholar
  49. Nishioka T et al (2006) CD4+CD25+Foxp3+ T-cells and CD4+CD25-Foxp3+ T-cells in aged mice. J Immunol 176(11):6586–6593CrossRefGoogle Scholar
  50. Nishioka T, Nishida E, Iida R, Morita A, Shimizu J (2008) In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. Immunol Lett 121(2):97–104CrossRefGoogle Scholar
  51. Oh J, Wang W, Thomas R, Su DM (2017) Capacity of tTreg generation is not impaired in the atrophied thymus. PLoS Biol 15(11):e2003352CrossRefGoogle Scholar
  52. Pacholczyk R et al (2006) Origin and T-cell receptor diversity of Foxp3+CD4+CD25+ T-cells. Immunity 25(2):249–259CrossRefGoogle Scholar
  53. Plitas G, Rudensky AY (2016) Regulatory T cells: differentiation and function. Cancer Immunol Res 4(9):721–725CrossRefGoogle Scholar
  54. Raynor J, Lages CS, Shehata H, Hildeman DA, Chougnet CA (2012) Homeostasis and function of regulatory T cells in aging. Curr Opin Immunol 24(4):482–487CrossRefGoogle Scholar
  55. Raynor J, Sholl A, Plas DR et al (2013) IL-15 fosters age-driven regulatory T cell accrual in the face of declining IL-2 levels. Front Immunol 4:161CrossRefGoogle Scholar
  56. Raynor J, Karns R, Almanan M, Li KP, Divanovic S, Chougnet CA, Hildeman DA (2015) IL-6 and ICOS antagonize Bim and promote regulatory T cell accrual with age. J Immunol 195(3):944–952CrossRefGoogle Scholar
  57. Rosenkranz D et al (2007) Higher frequency of regulatory T-cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 188(1–2):117–127CrossRefGoogle Scholar
  58. Sakaguchi S et al (1995) Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164PubMedGoogle Scholar
  59. Seddiki N et al (2006a) Persistence of naive CD45RA+ regulatory T-cells in adult life. Blood 107(7):2830–2838CrossRefGoogle Scholar
  60. Seddiki N et al (2006b) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T-cells. J Exp Med 203(7):1693–1700CrossRefGoogle Scholar
  61. Selvaraj RK, Geiger TL (2007) A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 178(12):7667–7677CrossRefGoogle Scholar
  62. Sharma S, Dominguez AL, Lustgarten J (2006) High accumulation of T-regulatory cells prevents the activation of immune responses in aged animals. J Immunol 177(12):8348–8355CrossRefGoogle Scholar
  63. Shimizu J, Moriizumi E (2003) CD4+CD25- T-cells in aged mice are hyporesponsive and exhibit suppressive activity. J Immunol 170(4):1675–1682CrossRefGoogle Scholar
  64. Sun L, Hurez VJ, Thibodeaux SR, Kious MJ, Liu A, Lin P, Murthy K, Pandeswara S, Shin T, Curiel TJ (2012) Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. Aging Cell 11(3):509–519CrossRefGoogle Scholar
  65. Suzuki M, Jagger AL, Konya C, Shimojima Y, Pryshchep S, Goronzy JJ, Weyand CM (2012) CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol 189(5):2118–2130CrossRefGoogle Scholar
  66. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Perals C, Leobon B, Fazilleau N, Joffre OP, Robey EA, van Meerwijk JP, Romagnoli P (2015) Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol 16(6):628–634CrossRefGoogle Scholar
  67. Thomas DC, Mellanby RJ, Phillips JM, Cooke A (2007) An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice. Immunology 121(4):565–576CrossRefGoogle Scholar
  68. Trzonkowski P, Szmit E, Myśliwska J, Myśliwski A (2006) CD4+CD25+ T-regulatory cells inhibit cytotoxic activity of CTL and NK-cells in humans-impact of immunosenescence. Clin Immunol 119(3):307–316CrossRefGoogle Scholar
  69. van der Geest KS, Abdulahad WH, Tete SM, Lorencetti PG, Horst G, Bos NA, Kroesen BJ, Brouwer E, Boots AM (2014) Aging disturbs the balance between effector and regulatory CD4+ T cells. Exp Gerontol 60:190–196CrossRefGoogle Scholar
  70. Vuddamalay Y, van Meerwijk JP (2017) CD28- and CD28lowCD8+ regulatory T cells: of mice and men. Front Immunol 8:31CrossRefGoogle Scholar
  71. Vukmanovic-Stejic M et al (2006) Human CD4+ CD25hi Foxp3+ regulatory T-cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116(9):2423–2433CrossRefGoogle Scholar
  72. Walker MR et al (2003) Induction of FoxP3 and acquisition of T-regulatory activity by stimulated human CD4+CD25- T-cells. J Clin Invest 112(9):1437–1443CrossRefGoogle Scholar
  73. Wang L, Xie Y, Zhu LJ, Chang TT, Mao YQ, Li J (2010) An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: a systematic review. Biomed Environ Sci 23(4):327–332CrossRefGoogle Scholar
  74. Wen Z, Wang X, Dong K, Zhang H, Bu Z, Ye L, Yang C (2017) Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice. Microbes Infect 19(12):626–634CrossRefGoogle Scholar
  75. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18–20CrossRefGoogle Scholar
  76. Williams-Bey Y, Jiang J, Murasko DM (2011) Expansion of regulatory T cells in aged mice following influenza infection. Mech Ageing Dev 132(4):163–170CrossRefGoogle Scholar
  77. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E (2002) Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106(2):190–199CrossRefGoogle Scholar
  78. Yadav M, Stephan S, Bluestone JA (2013) Peripherally induced tregs – role in immune homeostasis and autoimmunity. Front Immunol 4:232CrossRefGoogle Scholar
  79. Yang E, Zou T, Leichner TM, Zhang SL, Kambayashi T (2014) Both retention and recirculation contribute to long-lived regulatory T-cell accumulation in the thymus. Eur J Immunol 44(9):2712–2720CrossRefGoogle Scholar
  80. Zhao L et al (2007) Changes of CD4+CD25+Foxp3+ regulatory T-cells in aged Balb/c mice. J Leukoc Biol 81(6):1386–1394CrossRefGoogle Scholar
  81. Zheng SG et al (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172(9):5213–5221CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute of Immunology and ImmunotherapyUniversity of BirminghamBirminghamUK

Personalised recommendations